Product Information
GLYBURIDE 1.25 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0742 per EA under NDC 00093947753. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
1.25 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093947753
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLYBURIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017532On Market Since
5/1/1984
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE 1.25 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 38.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0742 per EA |
|---|---|
| All-time high | $0.1443 (Dec 11, 2019) |
| All-time low | $0.0561 (Jun 19, 2024) |
| 52-week high | $0.0873 |
| 52-week low | $0.0659 |
| Median price | $0.0947 |
| Average price | $0.0958 |
| Largest weekly change | +71.9% (Sep 18, 2019) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLYBURIDE 1.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE 1.25 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0742 per EA (NDC 00093947753), effective Jun 24, 2026.
How has the price of GLYBURIDE 1.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYBURIDE 1.25 MG TABLET has declined 38.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLYBURIDE 1.25 MG TABLET?
Since Nov 28, 2013, the NADAC for GLYBURIDE 1.25 MG TABLET has ranged from a low of $0.0561 (Jun 19, 2024) to a high of $0.1443 (Dec 11, 2019), with a median of $0.0947 per EA.
Are there cheaper alternatives to GLYBURIDE 1.25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as GLYBURIDE 1.25 MG TABLET, but none are currently priced below it.
Who manufactures GLYBURIDE 1.25 MG TABLET?
GLYBURIDE 1.25 MG TABLET (NDC 00093947753) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification